Taisuke Okumura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Taisuke Okumura has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Masayasu Urushibara
Department of Urology Teikyo University Hospital, Mizonokuchi Kawasaki Japan
2 shared publications Akihiro Kojima
Department of Urology Nissan Tamagawa Hospital Tokyo Japan
1 shared publication- Akihiro Kojima
Department of Urology Teikyo University Hospital, Mizonokuchi Kawasaki Japan
1 shared publication Daisuke Kato
Department of Urology Teikyo University Hospital, Mizonokuchi Kawasaki City Japan
1 shared publication- Daisuke Kato
Department of Urology Teikyo University Hospital, Mizonokuchi Kawasaki City Japan
1 shared publication Kazuhiro Ishizaka
Department of Urology Nissan Tamagawa Hospital Tokyo Japan
1 shared publication
Latest Publications
- Open Access
- 12 September 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (9) , e70877
Synchronous Ipsilateral Occurrence of Advanced Renal Pelvic Urothelial Carcinoma With Lung Metastasis and Localized Renal Cell Carcinoma: A Case Report
The patient was a 92‐year‐old woman who presented with a complaint of difficulty in urination. Her abdominal computed tomography (CT) revealed two distinct types of tumors in the lower and upper poles of the right kidney, and chest CT revealed multiple lung metastatic tumors. A laparoscopic right radical nephrectomy was performed, and the lower pole tumor was diagnosed as clear cell renal cell carcinoma (RCC), whereas the upper pole tumor was renal pelvic urothelial carcinoma (UC). The lung tumor was diagnosed as metastatic UC via CT‐guided biopsy. In this case, histological examination of the primary tumor site resection and immunohistochemical examination of the lung metastases were important in diagnosing metastatic UC. Despite the challenges associated with synchronous RCC and upper tract UC (UTUC), appropriate treatment strategies, including surgical intervention and systemic chemotherapy, may improve prognosis and prolong survival. The findings contribute to the limited knowledge on synchronous RCC and UTUC, offering valuable insights to help clinicians enhance decision‐making and improve patient care in similar scenarios.
- 12 September 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (9) , e70877
Open AccessSynchronous Ipsilateral Occurrence of Advanced Renal Pelvic Urothelial Carcinoma With Lung Metastasis and Localized Renal Cell Carcinoma: A Case Report
The patient was a 92‐year‐old woman who presented with a complaint of difficulty in urination. Her abdominal computed tomography (CT) revealed two distinct types of tumors in the lower and upper poles of the right kidney, and chest CT revealed multiple lung metastatic tumors. A laparoscopic right radical nephrectomy was performed, and the lower pole tumor was diagnosed as clear cell renal cell carcinoma (RCC), whereas the upper pole tumor was renal pelvic urothelial carcinoma (UC). The lung tumor was diagnosed as metastatic UC via CT‐guided biopsy. In this case, histological examination of the primary tumor site resection and immunohistochemical examination of the lung metastases were important in diagnosing metastatic UC. Despite the challenges associated with synchronous RCC and upper tract UC (UTUC), appropriate treatment strategies, including surgical intervention and systemic chemotherapy, may improve prognosis and prolong survival. The findings contribute to the limited knowledge on synchronous RCC and UTUC, offering valuable insights to help clinicians enhance decision‐making and improve patient care in similar scenarios.
- Open Access
- 18 August 2025
- Published by Wiley in Cancer Reports
- Vol. 8 (8) , e70317
Long‐Term Survival Obtained by Repeated Cytoreductive Surgery and S‐1 Plus Cisplatin Chemotherapy at Each Instance of Disease Progression in a Patient With Metastatic Urachal Carcinoma: A Case Report
Background: Urachal carcinoma (URC) is a rare tumor of the urinary bladder, of which the histology usually resembles that of colorectal adenocarcinoma. Achievement of cure in patients with metastatic URC is difficult, and the survival rate of these patients has remained unsatisfactory despite various efforts.Case: A 74‐year‐old female patient presented to us complaining of gross hematuria. Abdominal and thoracic computed tomography revealed a mass in the dome of the bladder with a single lung nodule. The two tumors, which were resected by partial cystectomy and video‐assisted thoracic surgery, respectively, were diagnosed by postoperative histopathology as adenocarcinomas. Subsequent to the surgeries, bilateral ovarian metastases and another lung metastasis, which appeared metachronously, were also resected. The repeated cytoreductive surgery combined with administration of S‐1 plus cisplatin chemotherapy at each instance of disease progression eventually yielded a durable progression‐free survival; even at 5 years after the initial therapy, the patient remained asymptomatic with no limitation of activities despite the failure to achieve “cure”.Conclusion: Not only some degree of sensitivity of the tumor to chemotherapy, but also the repeated cytoreductive surgeries might allow prolonged survival with a good quality of life in elderly patients with metastatic URC, even in the absence of cure and failure of genetic testing to suggest any potentially effective second‐line drugs. To improve the survival of patients with metastatic URC, complementary therapy suggested by the results of genomic profiling may be necessary along with other multimodality therapy, including sequential metastasectomy and chemotherapy.
- 18 August 2025
- Published by Wiley in Cancer Reports
- Vol. 8 (8) , e70317
Open AccessLong‐Term Survival Obtained by Repeated Cytoreductive Surgery and S‐1 Plus Cisplatin Chemotherapy at Each Instance of Disease Progression in a Patient With Metastatic Urachal Carcinoma: A Case Report
Background: Urachal carcinoma (URC) is a rare tumor of the urinary bladder, of which the histology usually resembles that of colorectal adenocarcinoma. Achievement of cure in patients with metastatic URC is difficult, and the survival rate of these patients has remained unsatisfactory despite various efforts.Case: A 74‐year‐old female patient presented to us complaining of gross hematuria. Abdominal and thoracic computed tomography revealed a mass in the dome of the bladder with a single lung nodule. The two tumors, which were resected by partial cystectomy and video‐assisted thoracic surgery, respectively, were diagnosed by postoperative histopathology as adenocarcinomas. Subsequent to the surgeries, bilateral ovarian metastases and another lung metastasis, which appeared metachronously, were also resected. The repeated cytoreductive surgery combined with administration of S‐1 plus cisplatin chemotherapy at each instance of disease progression eventually yielded a durable progression‐free survival; even at 5 years after the initial therapy, the patient remained asymptomatic with no limitation of activities despite the failure to achieve “cure”.Conclusion: Not only some degree of sensitivity of the tumor to chemotherapy, but also the repeated cytoreductive surgeries might allow prolonged survival with a good quality of life in elderly patients with metastatic URC, even in the absence of cure and failure of genetic testing to suggest any potentially effective second‐line drugs. To improve the survival of patients with metastatic URC, complementary therapy suggested by the results of genomic profiling may be necessary along with other multimodality therapy, including sequential metastasectomy and chemotherapy.
- Open Access
- 26 November 2023
- Published by Elsevier in Urology Case Reports
- Vol. 51, 102630
Intranodal glue embolization for lymphorrhea following inguinal lymphadenectomy in penile cancer: A case report
- 26 November 2023
- Published by Elsevier in Urology Case Reports
- Vol. 51, 102630
Open AccessIntranodal glue embolization for lymphorrhea following inguinal lymphadenectomy in penile cancer: A case report